These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1214 related items for PubMed ID: 11156399

  • 1. IL-2Ralpha-Directed monoclonal antibodies provide effective therapy in a murine model of adult T-cell leukemia by a mechanism other than blockade of IL-2/IL-2Ralpha interaction.
    Phillips KE, Herring B, Wilson LA, Rickford MS, Zhang M, Goldman CK, Tso JY, Waldmann TA.
    Cancer Res; 2000 Dec 15; 60(24):6977-84. PubMed ID: 11156399
    [Abstract] [Full Text] [Related]

  • 2. Activating Fc receptors are required for antitumor efficacy of the antibodies directed toward CD25 in a murine model of adult t-cell leukemia.
    Zhang M, Zhang Z, Garmestani K, Goldman CK, Ravetch JV, Brechbiel MW, Carrasquillo JA, Waldmann TA.
    Cancer Res; 2004 Aug 15; 64(16):5825-9. PubMed ID: 15313926
    [Abstract] [Full Text] [Related]

  • 3. Effective therapy for a murine model of adult T-cell leukemia with the humanized anti-CD52 monoclonal antibody, Campath-1H.
    Zhang Z, Zhang M, Goldman CK, Ravetch JV, Waldmann TA.
    Cancer Res; 2003 Oct 01; 63(19):6453-7. PubMed ID: 14559836
    [Abstract] [Full Text] [Related]

  • 4. Interleukin-2 receptor (Tac antigen) expressed on adult T cell leukemia cells.
    Uchiyama T, Hori T, Tsudo M, Wano Y, Umadome H, Tamori S, Yodoi J, Maeda M, Sawami H, Uchino H.
    J Clin Invest; 1985 Aug 01; 76(2):446-53. PubMed ID: 2993359
    [Abstract] [Full Text] [Related]

  • 5. TCGF (IL 2)-receptor inducing factor(s). I. Regulation of IL 2 receptor on a natural killer-like cell line (YT cells).
    Yodoi J, Teshigawara K, Nikaido T, Fukui K, Noma T, Honjo T, Takigawa M, Sasaki M, Minato N, Tsudo M.
    J Immunol; 1985 Mar 01; 134(3):1623-30. PubMed ID: 2578514
    [Abstract] [Full Text] [Related]

  • 6. Interleukin-2 receptor expression in retrovirus associated adult T-cell leukemia.
    Waldmann TA, Leonard WJ, Depper JM, Krönke M, Goldman CK, Oh T, Greene WC.
    Princess Takamatsu Symp; 1984 Mar 01; 15():259-68. PubMed ID: 6100644
    [Abstract] [Full Text] [Related]

  • 7. Neutrophils contribute to the biological antitumor activity of rituximab in a non-Hodgkin's lymphoma severe combined immunodeficiency mouse model.
    Hernandez-Ilizaliturri FJ, Jupudy V, Ostberg J, Oflazoglu E, Huberman A, Repasky E, Czuczman MS.
    Clin Cancer Res; 2003 Dec 01; 9(16 Pt 1):5866-73. PubMed ID: 14676108
    [Abstract] [Full Text] [Related]

  • 8. Anti-CD7 antibody and immunotoxin treatment of human CD7(+)T-cell leukaemia is significantly less effective in NOD/LtSz-scid mice than in CB.17 scid mice.
    Flavell DJ, Warnes SL, Noss AL, Flavell SU.
    Br J Cancer; 2000 Dec 01; 83(12):1755-61. PubMed ID: 11104577
    [Abstract] [Full Text] [Related]

  • 9. Radioimmunotherapy of nude mice bearing a human interleukin 2 receptor alpha-expressing lymphoma utilizing the alpha-emitting radionuclide-conjugated monoclonal antibody 212Bi-anti-Tac.
    Hartmann F, Horak EM, Garmestani K, Wu C, Brechbiel MW, Kozak RW, Tso J, Kosteiny SA, Gansow OA, Nelson DL.
    Cancer Res; 1994 Aug 15; 54(16):4362-70. PubMed ID: 8044783
    [Abstract] [Full Text] [Related]

  • 10. Defucosylated anti-CCR4 monoclonal antibody exerts potent ADCC against primary ATLL cells mediated by autologous human immune cells in NOD/Shi-scid, IL-2R gamma(null) mice in vivo.
    Ito A, Ishida T, Utsunomiya A, Sato F, Mori F, Yano H, Inagaki A, Suzuki S, Takino H, Ri M, Kusumoto S, Komatsu H, Iida S, Inagaki H, Ueda R.
    J Immunol; 2009 Oct 01; 183(7):4782-91. PubMed ID: 19748990
    [Abstract] [Full Text] [Related]

  • 11. Antileukemia activity of a natural killer cell line against human leukemias.
    Yan Y, Steinherz P, Klingemann HG, Dennig D, Childs BH, McGuirk J, O'Reilly RJ.
    Clin Cancer Res; 1998 Nov 01; 4(11):2859-68. PubMed ID: 9829753
    [Abstract] [Full Text] [Related]

  • 12. Host-mediated antibody-dependent cellular cytotoxicity contributes to the in vivo therapeutic efficacy of an anti-CD7-saporin immunotoxin in a severe combined immunodeficient mouse model of human T-cell acute lymphoblastic leukemia.
    Flavell DJ, Warnes S, Noss A, Flavell SU.
    Cancer Res; 1998 Dec 15; 58(24):5787-94. PubMed ID: 9865737
    [Abstract] [Full Text] [Related]

  • 13. Use of an antibody against the soluble interleukin 2 receptor alpha subunit can modulate the stability and biodistribution of interleukin-2.
    Kobayashi H, Tagaya Y, Han ES, Kim IS, Le N, Paik CH, Pastan I, Nelson DL, Waldmann TA, Carrasquillo JA.
    Cytokine; 1999 Dec 15; 11(12):1065-75. PubMed ID: 10623432
    [Abstract] [Full Text] [Related]

  • 14. Combination therapy for adult T-cell leukemia-xenografted mice: flavopiridol and anti-CD25 monoclonal antibody.
    Zhang M, Zhang Z, Goldman CK, Janik J, Waldmann TA.
    Blood; 2005 Feb 01; 105(3):1231-6. PubMed ID: 15383455
    [Abstract] [Full Text] [Related]

  • 15. IMC-EB10, an anti-FLT3 monoclonal antibody, prolongs survival and reduces nonobese diabetic/severe combined immunodeficient engraftment of some acute lymphoblastic leukemia cell lines and primary leukemic samples.
    Piloto O, Nguyen B, Huso D, Kim KT, Li Y, Witte L, Hicklin DJ, Brown P, Small D.
    Cancer Res; 2006 May 01; 66(9):4843-51. PubMed ID: 16651440
    [Abstract] [Full Text] [Related]

  • 16. Natural killer cells activated by interleukin 2 treatment in vivo respond to interleukin 2 primarily through the p75 receptor and maintain the p55 (TAC) negative phenotype.
    Weil-Hillman G, Voss SD, Fisch P, Schell K, Hank JA, Sosman JA, Sugamura K, Sondel PM.
    Cancer Res; 1990 May 01; 50(9):2683-91. PubMed ID: 1691679
    [Abstract] [Full Text] [Related]

  • 17. Humanized antibody directed to the IL-2 receptor beta-chain prolongs primate cardiac allograft survival.
    Tinubu SA, Hakimi J, Kondas JA, Bailon P, Familletti PC, Spence C, Crittenden MD, Parenteau GL, Dirbas FM, Tsudo M.
    J Immunol; 1994 Nov 01; 153(9):4330-8. PubMed ID: 7930631
    [Abstract] [Full Text] [Related]

  • 18. Abnormal expression of interleukin-2 receptor (Tac antigen) in adult T-cell leukemia.
    Uchiyama T, Wano Y, Tsudo M, Umadome H, Hori T, Tamori S, Uchino H, Yodoi J, Maeda M, Kobayashi N.
    Princess Takamatsu Symp; 1984 Nov 01; 15():253-8. PubMed ID: 6100643
    [Abstract] [Full Text] [Related]

  • 19. Expression of functional interleukin-21 receptor on adult T-cell leukaemia cells.
    Ueda M, Imada K, Imura A, Koga H, Hishizawa M, Uchiyama T.
    Br J Haematol; 2005 Jan 01; 128(2):169-76. PubMed ID: 15638850
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 61.